litlas
Log inCreate account

Michele Reni

Active 1996–2025

108
Papers
22,519
Citations
72
h-index
100
i10-index

Citations

Citations per year for Michele Reni1991: 1 citations1999: 9 citations2000: 8 citations2001: 11 citations2002: 22 citations2003: 32 citations2004: 36 citations2005: 38 citations2006: 52 citations2007: 60 citations2008: 77 citations2009: 71 citations2010: 106 citations2011: 77 citations2012: 89 citations2013: 102 citations2014: 128 citations2015: 160 citations2016: 168 citations2017: 211 citations2018: 221 citations2019: 782 citations2020: 1,027 citations2021: 1,022 citations2022: 742 citations2023: 491 citations2024: 853 citations2025: 323 citations2026: 11 citations1992–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,171 citing papers, 24.2% of this breakdownChina: 954 citing papers, 10.6% of this breakdownItaly: 699 citing papers, 7.8% of this breakdownGermany: 600 citing papers, 6.7% of this breakdownUnited Kingdom: 486 citing papers, 5.4% of this breakdownFrance: 462 citing papers, 5.1% of this breakdownJapan: 434 citing papers, 4.8% of this breakdownNetherlands: 308 citing papers, 3.4% of this breakdownCanada: 288 citing papers, 3.2% of this breakdownSpain: 277 citing papers, 3.1% of this breakdownAustralia: 217 citing papers, 2.4% of this breakdownSwitzerland: 217 citing papers, 2.4% of this breakdown
0%24.2%Other 20.9%

Institutions

Fields

  • Medicine76.5%
  • Biochemistry, Genetics and Molecular Biology13.7%
  • Immunology and Microbiology3.6%
  • Materials Science1.7%
  • Physics and Astronomy1.3%
  • Engineering1.1%
  • Other2.1%

Topics

  • Pancreatic and Hepatic Oncology Research14.1%
  • Glioma Diagnosis and Treatment5.3%
  • Cancer Genomics and Diagnostics3.8%
  • Cancer Immunotherapy and Biomarkers3.1%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.6%
  • CNS Lymphoma Diagnosis and Treatment2.6%
  • Other68.5%

Coauthors

All papers

Open in search
  1. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

    Authors: Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, E. Gabriela Chiorean, Jeffrey R. Infante, Malcolm J. Moore, Thomas E. Seay, Sergei Tjulandin, Wen Wee, Mansoor N. Saleh, Marion Harris, Michele Reni, Scot Dowden, Daniel A. Laheru, Nathan Bahary, Ramesh K. Ramanathan, Josep Tabernero, Manuel Hidalgo, David Goldstein, Eric Van Cutsem, Xinyu Wei, José Iglesias, Markus F. Renschler - New England Journal of Medicine 2013 cited by 6,661

  2. Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer

    Authors: Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do‐Youn Oh, Anke Reinacher‐Schick, Giampaolo Tortora, Hana Algül, Eileen M. O’Reilly, David McGuinness, Karen Cui, Katia Schlienger, Gershon Y. Locker, Hedy L. Kindler - New England Journal of Medicine 2019 cited by 2,213

  3. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer

    Authors: Hedy L. Kindler, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall, Joon Oh Park, Daniel Hochhauser, Dirk Arnold, Do‐Youn Oh, Anke Reinacher‐Schick, Giampaolo Tortora, Hana Algül, Eileen M. O’Reilly, Sonal Bordia, David McGuinness, Karen Cui, Gershon Y. Locker, Talia Golan - Journal of Clinical Oncology 2022 cited by 225

  4. Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

    Authors: Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly, Jordan M. Winter, Do‐Youn Oh, Chung‐Pin Li, Giampaolo Tortora, Heung-Moon Chang, Charles D. Lopez, Tanios Bekaii‐Saab, Andrew H. Ko, Armando Santoro, Joon Oh Park, Marcus Smith Noel, Giovanni Luca Frassineti, Yan‐Shen Shan, Andrew Dean, Hanno Riess, Eric Van Cutsem, Jordan Berlin, Philip Philip, Malcolm J. Moore, David Goldstein, Josep Tabernero, Mingyu Li, Stefano Ferrara, Yvan Le Bruchec, George Zhang, Brian Lu, Andrew V. Biankin, Michele Reni, Richard A. Epstein, Paul L. Vasey, Jeremy Shapiro, Matthew Burge, Yu Jo Chua, Marion Harris, Nick Pavlakis, Niall C. Tebbutt, Gerald W. Prager, Christian Dittrich, Friedrich Längle, Kathrin Philipp‐Abbrederis, Richard Greil, Herbert Stöger, Michael Girschikofsky, Thomas Kuehr, Jean–Luc Van Laethem, Stéphanie Laurent, Neesha C. Dhani, Yoo Joung Ko, Scot Dowden, Petr Kavan, Mustapha Édouard Tehfe, Eugen Kubala, Milan Kohoutek, Per Pfeiffer, Mette Yilmaz, Vibeke K. Parner, Tapio Salminen, Leena‐Maija Soveri, Eija Korkeila, Pia Österlund, Julien Taı̈eb, David Tougeron, Pascal Artru, François‐Xavier Caroli‐Bosc, Rosine Guimbaud, Antony Turpin, Thomas Walter, Jean‐Baptiste Bachet, Volker Kunzmann, Florian Kreth, Andreas De Block, Marino Venerito, Helmut Oettle, Meinolf Karthaus, Jörg Trojan, Gunnar Folprecht, Markus M. Lerch, Frank Kullmann, Marcel Reiser, Volker Heinemann, Marcus‐Alexander Wörns, H. Schulz, Benjamin Garlipp, Thomas Yau, Lam Stephen Chan, Balázs Juhász, László Landherr, Tamás Pintér, G. Bodoky, Zsuzsanna Kahán, Raymond McDermott, Derek G. Power, Luca Gianni, Salvatore Siena, Michèle Milella, Alfredo Falcone, Rossana Berardi and 87 more - Journal of Clinical Oncology 2022 cited by 132

  5. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer

    Authors: Lucia De Monte, Michele Reni, Elena Tassi, Daniela Clavenna, Ilenia Papa, Helios Recalde, Marco Braga, Valerio Di Carlo, Claudio Doglioni, Maria Pia Protti - The Journal of Experimental Medicine 2011 cited by 692

  6. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

    Authors: Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Valter Torri, Christopher P. Fox, Paul La Rosée, Elisabeth Schorb, Achille Ambrosetti, Alexander Röth, Claire Hemmaway, Angela Ferrari, Kim Linton, Roberta Rudà, Mascha Binder, Tobias Pukrop, Monica Balzarotti, Alberto Fabbri, Peter Johnson, Jette Sønderskov Gørløv, Georg Heß, Jens Panse, Francesco Pisani, Alessandra Tucci, Stephan Stilgenbauer, Bernd Hertenstein, Ulrich Keller, Stefan W. Krause, Alessandro Levis, Hans‐Joachim Schmoll, Franco Cavalli, Jürgen Finke, Michele Reni, Emanuele Zucca, Gerald Illerhaus - The Lancet Haematology 2016 cited by 599

  7. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

    Authors: Brigitta G. Baumert, Monika E. Hegi, Martin J. van den Bent, Andreas von Deimling, Thierry Gorlia, Khê Hoang‐Xuan, Alba A. Brandes, Guy Kantor, Martin J B Taphoorn, Mohamed Ben Hassel, Christian Hartmann, Gail Ryan, David Capper, Johan M. Kros, Sebastian Kurscheid, Wolfgang Wick, Roelien H. Enting, Michele Reni, Brian Thiessen, F. Dhermain, Jacoline E. C. Bromberg, L. Feuvret, Jaap C. Reijneveld, Olivier Chinot, Johanna M. M. Gijtenbeek, John P. Rossiter, Nicolas Dif, Carmen Balañá, Jose Bravo-Marques, Paul M. Clément, Christine Marosi, Tzahala Tzuk-Shina, Robert Nordal, Jeremy Rees, Denis Lacombe, Warren Mason, Roger Stupp - The Lancet Oncology 2016 cited by 498

  8. Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial

    Authors: Michele Reni, Gianpaolo Balzano, Silvia Zanon, Alessandro Zerbi, Lorenza Rimassa, R. Castoldi, D. Pinelli, Stefania Mosconi, Claudio Doglioni, Marta Chiaravalli, Chiara Pircher, Paolo Giorgio Arcidiacono, Valter Torri, Paola Maggiora, Domenica Ceraulo, Massimo Falconi, Luca Gianni - ˜The œLancet. Gastroenterology & hepatology 2018 cited by 254

  9. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

    Authors: Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski, Christopher P. Fox, Elisabeth Schorb, Paul La Rosée, Mascha Binder, Alberto Fabbri, Valter Torri, Eleonora Minacapelli, Monica Falautano, Fiorella Ilariucci, Achille Ambrosetti, Alexander Röth, Claire Hemmaway, Peter Johnson, Kim Linton, Tobias Pukrop, Jette Sønderskov Gørløv, Monica Balzarotti, Georg Heß, Ulrich Keller, Stephan Stilgenbauer, Jens Panse, Alessandra Tucci, Lorella Orsucci, Francesco Pisani, Alessandro Levis, Stefan W. Krause, Hans‐Joachim Schmoll, Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Michael Pfreundschuh, Giuseppina Cabras, F. Angrilli, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Jürgen Finke, Michele Reni, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus - The Lancet Haematology 2017 cited by 381

  10. Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    Authors: Andrés J.M. Ferreri, Jean‐Yves Blay, Michele Reni, Felice Pasini, Michele Spina, Achille Ambrosetti, Antonello Calderoni, Andrea Rossi, V. Vavassori, Annarita Conconi, Liliana Devizzi, Françoise Berger, Maurilio Ponzoni, Bettina Borisch, Marianne Tinguely, Michele Cerati, Mario Milani, Enrico Orvieto, Juvenal Sánchez, Christine Chevreau, Stefania Dell’Oro, Emanuele Zucca, Franco Cavalli - Journal of Clinical Oncology 2003 cited by 840

  11. EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting

    Authors: Giuseppe Vanella, Giuseppe Dell’Anna, Gabriele Capurso, Patrick Maisonneuve, Michiel Bronswijk, Stefano Crippa, Domenico Tamburrino, Marina Macchini, Giulia Orsi, Andrea Casadei‐Gardini, Luca Aldrighetti, Michele Reni, Massimo Falconi, Van der Merwe, Paolo Giorgio Arcidiacono - Gastrointestinal Endoscopy 2023 cited by 66

  12. Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

    Authors: Margaret A. Tempero, Do‐Youn Oh, Josep Tabernero, Michele Reni, Eric Van Cutsem, Andrew Hendifar, Dirk Waldschmidt, Naureen Starling, Jean‐Baptiste Bachet, Heung Moon Chang, Joan Maurel, Rocio García‐Carbonero, Sara Lonardi, Lisa M. Coussens, Lawrence Fong, L. Claire Tsao, George W. Cole, Danelle F. James, Teresa Macarulla - Annals of Oncology 2021 cited by 114

  13. Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

    Authors: Tanios Bekaii‐Saab, Takuji Okusaka, David Goldstein, Do‐Youn Oh, Makoto Ueno, Tatsuya Ioka, Weijia Fang, Eric Anderson, Marcus Smith Noel, Michele Reni, Hye Jin Choi, Jonathan S. Goldberg, Sang Cheul Oh, Chung‐Pin Li, Josep Tabernero, Jian Li, Emma Foos, Cindy Oh, Eric Van Cutsem - EClinicalMedicine 2023 cited by 30

  14. Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients

    Authors: Lucia De Monte, Sonja M. Wörmann, Emanuela Brunetto, Silvia Heltai, Gilda Magliacane, Michele Reni, Anna Maria Paganoni, Helios Recalde, Anna Mondino, Massimo Falconi, Francesca Aleotti, Gianpaolo Balzano, Hana Algül, Claudio Doglioni, Maria Pia Protti - Cancer Research 2016 cited by 157

  15. The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma

    Authors: Federica Marchesi, Lorenzo Piemonti, Giuseppe Fedele, Annarita Destro, Massimo Roncalli, Luca Albarello, Claudio Doglioni, Achille Anselmo, Andrea Doni, Paolo Bianchi, Luigi Laghi, Alberto Malesci, Luigi Cervo, Maria Luisa Malosio, Michele Reni, Alessandro Zerbi, Valerio Di Carlo, Alberto Mantovani, Paola Allavena - Cancer Research 2008 cited by 195

  16. Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies

    Authors: A. Nuccio, Giuseppe Viscardi, Fabio Salomone, Alberto Servetto, F.M. Venanzi, Silvia Teresa Riva, Sara Oresti, Francesca Rita Ogliari, Mariagrazia Viganò, Alessandra Bulotta, Robert B. Cameron, A. Esposito, Jacobi Hines, Roberto Bianco, Michele Reni, Tina Cascone, Marina Chiara Garassino, Valter Torri, Giulia Veronesi, Michela Cinquini, Roberto Ferrara - European Journal of Cancer 2023 cited by 37

  17. Meningioma

    Authors: Christine Marosi, Marco Hassler, Karl Rössler, Michele Reni, Milena Sant, Elena Mazza, Charles J. Vecht - Critical Reviews in Oncology/Hematology 2008 cited by 374

  18. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

    Authors: Andrés JM Ferreri, Michele Reni, Marco Foppoli, Maurizio Martelli, Gerasimus A Pangalis, Maurizio Frezzato, Maria Giuseppina Cabras, Alberto Fabbri, Gaetano Corazzelli, Fiorella Ilariucci, Giuseppe Rossi, Riccardo Soffietti, Caterina Stelitano, Daniele Vallisa, Francesco Zaja, Lucía Zoppegno, Gian Marco Aondio, Giuseppe Avvisati, Monica Balzarotti, Alba A. Brandes, José Fajardo, Henry Gómez, Attilio Guarini, Graziella Pinotti, Luigi Rigacci, Catrina Uhlmann, Piero Picozzi, Paolo Vezzulli, Maurilio Ponzoni, Emanuele Zucca, Federico Caligaris‐Cappio, Franco Cavalli - The Lancet 2009 cited by 662

  19. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer

    Authors: Paolo Giorgio Arcidiacono, Silvia Carrara, Michele Reni, Maria Chiara Petrone, Stefano Cappio, Gianpaolo Balzano, Cinzia Boemo, Stefano Cereda, Roberto Nicoletti, Markus D. Enderle, Alexander Neugebauer, Daniel von Renteln, Axel Eickhoff, Pier Alberto Testoni - Gastrointestinal Endoscopy 2012 cited by 169

  20. Central nervous system gliomas

    Authors: Michele Reni, Elena Mazza, Silvia Zanon, Gemma Gatta, Charles J. Vecht - Critical Reviews in Oncology/Hematology 2017 cited by 150

  21. Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy?

    Authors: Stefano Crippa, Alessandro Bittoni, Enrico Sebastiani, Stefano Partelli, Silvia Zanon, Andrea Lanese, Kalliopi Andrikou, Francesca Muffatti, Gianpaolo Balzano, Michele Reni, Stefano Cascinu, Massimo Falconi - European Journal of Surgical Oncology 2016 cited by 140

  22. Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma

    Authors: Michele Reni, Silvia Zanon, Gianpaolo Balzano, Sara Nobile, C.C. Pircher, Marta Chiaravalli, Paolo Passoni, Paolo Giorgio Arcidiacono, Roberto Nicoletti, Stefano Crippa, N. Slim, Claudio Doglioni, Massimo Falconi, Luca Gianni - Annals of Oncology 2017 cited by 110

  23. Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial

    Authors: René-Olivier Mirimanoff, Thierry Gorlia, Warren Mason, Martin J. van den Bent, Rolf‐Dieter Kortmann, Barbara Fisher, Michele Reni, Alba A. Brandes, J. Curschmann, S. Villà, Gregory Cairncross, Anouk Allgeier, Denis Lacombe, Roger Stupp - Journal of Clinical Oncology 2006 cited by 508

  24. (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial

    Authors: Michele Reni, Erica Dugnani, Stefano Cereda, Carmen Belli, Gianpaolo Balzano, Roberto Nicoletti, Daniela Liberati, Valentina Pasquale, Marina Scavini, Paola Maggiora, Valeria Sordi, Vito Lampasona, Domenica Ceraulo, Gaetano Di Terlizzi, Claudio Doglioni, Massimo Falconi, Lorenzo Piemonti - Clinical Cancer Research 2015 cited by 170